New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
19:13 EDTELX, BERY, PMCS, TLAB, BUD, TSYS, PWER, CTCT, SPF, ADNCOn The Fly: After Hours Movers
UP AFTER EARNINGS: Audience (ADNC), up 25.1%... TeleCommunication Systems (TSYS), up 11.9%... PMC-Sierra (PMCS), up 7.2%... Standard Pacific (SPF), up 4.4%... ALSO HIGHER: Anheuser-Busch InBev (BUD), 0.1% after DoJ announced earlier today it was suing to block the company's planned acquisition of Grupo Modelo... DOWN AFTER EARNINGS: Berry Plastics (BERY), down 8.9%... Constant Contact (CTCT) down 6.3%... Tellabs (TLAB), down 3.9%... Emulex (ELX), down 3.2%... Power-One (PWER), down 2.9%.
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
11:49 EDTBUDAsahi confirms offer to buy Peroni, Grolsch from SABMiller
Subscribe for More Information
08:32 EDTBERYBerry Plastics raises FY16 EBITDA guidance, reaffirms adjusted FCF view
The company says, "Given the strong start to our fiscal year we are now increasing our operating EBITDA guidance for the 2016 fiscal year by $20 million to $1,180 million. The benefits we anticipated from the Avintiv acquisition are on track and exceeding initial estimates. Today, we are reaffirming our fiscal 2016 adjusted free cash flow guidance of $475 million assuming no significant impact from resin cost changes. The estimate includes cash flow from operating activities of $817 million less $285 million of net additions to property, plant, and equipment and the $57 million tax receivable agreement payment made in October 2015. A key priority remains debt reduction with a goal to lower our overall leverage by a half turn per year. Consistent with this goal, we have voluntarily used $150 million for early debt retirement since the start of the fiscal year in October 2015."
08:31 EDTBERYBerry Plastics reports Q1 adjusted EPS 35c, consensus 40c
Reports Q1 revenue $1.61B, consensus $1.65B.
February 9, 2016
17:21 EDTCTCTSurgical Care Affiliates to replace Constant Contact in S&P 600 as of 2/11 close
Endurance International Group Holdings (EIGI) is acquiring Constant Contact (CTCT) in a deal that was completed February 9.
15:14 EDTCTCTEndurance International announces closing of Constant Contact acquisition
Subscribe for More Information
Subscribe for More Information
09:25 EDTCTCTOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Wendy's (WEN), up 3.5%. ALSO HIGHER: ITC Holdings (ITC), up 1.1% after being acquired by Fortis for in a deal valued at $11.3B... Kinross Gold (KGC), up 2.9% after being upgraded to Outperform from Neutral at Credit Suisse... Boston Scientific (BSX), up 3.1% after announcing that Medicare will cover Watchman left atrial appendage closure Device. DOWN AFTER EARNINGS: Regeneron (REGN), down 7.2%... Twenty-First Century Fox (FOXA, FOX), down 6.7% and 2.6%, respectively... CVS Health (CVS), down 3.5%... Viacom (VIAB), down 3.2%. ALSO LOWER: Constant Contact (CTCT), down 3.3% after Bloomberg reported that Endurance International (EIGI) withdrew a $735M loan Monday that was intended to help fund its $1.1B takeover of the company... Paypal (PYPL), down 2.4% after announcing a Chief Technology Officer transition.
08:54 EDTCTCTEndurance pulls loan earmarked for Constant Contact takeover, Bloomberg says
Endurance International (EIGI) withdrew a $735M loan Monday that was intend to help fund its $1.1B takeover of Constant Contact (CTCT), reported Bloomberg, citing a person with knowledge of the matter. A representative for Endurance didn't immediately respond to a telephone call seeking comment, the report noted. Shares of Constant Contact are down 5% in pre-market trading following the report.
February 8, 2016
14:01 EDTBUDEarnings Watch: Analysts becoming more positive on Coca-Cola
Subscribe for More Information
February 3, 2016
08:05 EDTTSYSComtech extends tender offer for TeleCommunication Systems until February 18
Subscribe for More Information
February 1, 2016
08:45 EDTBERYBerry Plastics reinstating with an Outperform at Credit Suisse
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use